Marker TherapeuticsMRKR
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$5.43avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Ar Asset Management Inc. ($384K).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L107
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Ar Asset Management Inc. | 0.09% | No change | 70,700 | $384K |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.